Clinical trial
Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System
NCT01687036 is registered in ClinicalTrials.gov with afreeze GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System
- Lead sponsor
- afreeze GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- June 30, 2013
- Enrollment
- 10 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.